These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 8280652)

  • 1. Protracted drug infusions in cancer treatment: an appraisal of 5-fluorouracil, doxorubicin, and platinums.
    DelaFlor-Weiss E; Uziely B; Muggia FM
    Ann Oncol; 1993 Nov; 4(9):723-33. PubMed ID: 8280652
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A phase III randomized study of 5-fluorouracil and cisplatin versus 5-fluorouracil, doxorubicin, and mitomycin C versus 5-fluorouracil alone in the treatment of advanced gastric cancer.
    Kim NK; Park YS; Heo DS; Suh C; Kim SY; Park KC; Kang YK; Shin DB; Kim HT; Kim HJ
    Cancer; 1993 Jun; 71(12):3813-8. PubMed ID: 8508349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of costs for infusion versus bolus chemotherapy administration: analysis of five standard chemotherapy regimens in three common tumors--Part one. Model projections for cost based on charges.
    Lokich JJ; Moore CL; Anderson NR
    Cancer; 1996 Jul; 78(2):294-9. PubMed ID: 8674006
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protracted intravenous infusion of 5-fluorouracil in combination treatments. A review.
    Hansen RM
    Acta Oncol; 1991; 30(1):7-10. PubMed ID: 2009187
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neoadjuvant therapy of high-risk gastric cancer: a phase II trial of preoperative FAMTX and postoperative intraperitoneal fluorouracil-cisplatin plus intravenous fluorouracil.
    Kelsen D; Karpeh M; Schwartz G; Gerdes H; Lightdale C; Botet J; Lauers G; Klimstra D; Huang Y; Saltz L; Quan V; Brennan M
    J Clin Oncol; 1996 Jun; 14(6):1818-28. PubMed ID: 8656250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase II trial of cisplatin, interferon alpha-2b, doxorubicin, and 5-fluorouracil for biliary tract cancer.
    Patt YZ; Hassan MM; Lozano RD; Waugh KA; Hoque AM; Frome AI; Lahoti S; Ellis L; Vauthey JN; Curley SA; Schnirer II; Raijman I
    Clin Cancer Res; 2001 Nov; 7(11):3375-80. PubMed ID: 11705850
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized comparison of weekly cisplatin or protracted venous infusion of fluorouracil in combination with pelvic radiation in advanced cervix cancer: a gynecologic oncology group study.
    Lanciano R; Calkins A; Bundy BN; Parham G; Lucci JA; Moore DH; Monk BJ; O'Connor DM
    J Clin Oncol; 2005 Nov; 23(33):8289-95. PubMed ID: 16230678
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Continuous infusion 5-fluorouracil with bolus adriamycin and mitomycin and low-dose cisplatin (FAMP) in the treatment of metastatic gastric carcinoma: an evaluation of efficacy and toxicity.
    Raschko JW; Johnson EA; Ueno W; Woolley PV; Treat J
    Cancer Invest; 1991; 9(1):49-51. PubMed ID: 2012996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase III study of bolus versus infusion fluorouracil with or without cisplatin in advanced colorectal cancer.
    Hansen RM; Ryan L; Anderson T; Krzywda B; Quebbeman E; Benson A; Haller DG; Tormey DC
    J Natl Cancer Inst; 1996 May; 88(10):668-74. PubMed ID: 8627643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concurrent chemoradiotherapy for esophageal cancer: comparison between intermittent standard-dose cisplatin with 5-fluorouracil and daily low-dose cisplatin with continuous infusion of 5-fluorouracil.
    Sai H; Mitsumori M; Yamauchi C; Araki N; Okumura S; Nagata Y; Nishimura Y; Hiraoka M
    Int J Clin Oncol; 2004 Jun; 9(3):149-53. PubMed ID: 15221597
    [TBL] [Abstract][Full Text] [Related]  

  • 11. First-line protracted venous infusion fluorouracil with CisDDP or carboplatin in advanced colorectal cancer.
    Garcia-Giralt E; Beuzeboc P; Deffontaines D; Diéras V; Dorval T; Jouve M; Palangie T; Scholl S; Pouillart P
    J Infus Chemother; 1996; 6(3):149-51. PubMed ID: 9229328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase II randomized trial of gallium nitrate plus fluorouracil versus methotrexate, vinblastine, doxorubicin, and cisplatin in patients with advanced transitional-cell carcinoma.
    McCaffrey JA; Hilton S; Mazumdar M; Sadan S; Heineman M; Hirsch J; Kelly WK; Scher HI; Bajorin DF
    J Clin Oncol; 1997 Jun; 15(6):2449-55. PubMed ID: 9196161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Continuous venous infusion in cancer chemotherapy].
    Ota K
    Gan To Kagaku Ryoho; 1985 Apr; 12(4):798-805. PubMed ID: 2580486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Continuous infusion or bolus injection in cancer chemotherapy.
    Carlson RW; Sikic BI
    Ann Intern Med; 1983 Dec; 99(6):823-33. PubMed ID: 6197002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Continuous infusion of 5-fluorouracil plus low-dose cisplatin in tumor-bearing mice.
    Kamano T; Mikami Y; Shirasaka T
    Anticancer Drugs; 1997 Jul; 8(6):632-6. PubMed ID: 9300579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protracted infusion of 5-FU with weekly low-dose cisplatin as second-line therapy in patients with metastatic colorectal cancer who have failed 5-FU monotherapy.
    Ahlgren JD; Trocki O; Gullo JJ; Goldberg R; Muir WA; Sisk R; Schacter L
    Cancer Invest; 1991; 9(1):27-33. PubMed ID: 2012994
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A phase III randomized trial of 5-fluorouracil, doxorubicin, and mitomycin C versus 5-fluorouracil and mitomycin C versus 5-fluorouracil alone in curatively resected gastric cancer.
    Chang HM; Jung KH; Kim TY; Kim WS; Yang HK; Lee KU; Choe KJ; Heo DS; Bang YJ; Kim NK
    Ann Oncol; 2002 Nov; 13(11):1779-85. PubMed ID: 12419751
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase I study of 5-fluorouracil administered by protracted venous infusion, leucovorin, and pelvic radiation therapy.
    Martenson JA; Shanahan TG; O'Connell MJ; Cobau CD; Schroeder G; Burch PA; Levitt R; Rowland KM
    Cancer; 1999 Aug; 86(4):710-4. PubMed ID: 10440700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elimination of dose limiting toxicities of cisplatin, 5-fluorouracil, and leucovorin using a weekly 24-hour infusion schedule for the treatment of patients with nasopharyngeal carcinoma.
    Chi KH; Chan WK; Shu CH; Law CK; Chen SY; Yen SH; Chen KY
    Cancer; 1995 Dec; 76(11):2186-92. PubMed ID: 8635020
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An analysis of the therapeutic efficacy of protracted infusion of low-dose 5-fluorouracil and cisplatin in advanced gastric cancer.
    Kim R; Nishimoto N; Inoue H; Yoshida K; Toge T
    J Infect Chemother; 2000 Dec; 6(4):222-8. PubMed ID: 11810570
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.